1. Guo, Xiaobo, Yang, Ziguo, Zhi, Qiaoming, Shi, Yulong, Kuang, Yuting. . Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer. In Oncotarget, 7, 30276-94. doi:10.18632/oncotarget.7217. https://pubmed.ncbi.nlm.nih.gov/26863570/
2. Li, Wei, Fu, Qiang, Man, Wenling, Guo, Huanqing, Yang, Po. 2019. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway. In European journal of pharmacology, 849, 106-114. doi:10.1016/j.ejphar.2019.01.049. https://pubmed.ncbi.nlm.nih.gov/30710550/
3. Shang, J, Xu, Y-D, Zhang, Y-Y, Li, M. . Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1. In European review for medical and pharmacological sciences, 23, 4220-4225. doi:10.26355/eurrev_201905_17926. https://pubmed.ncbi.nlm.nih.gov/31173293/
4. Meng, Hongwei, Zhao, Bin, Wang, Yachao. 2020. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway. In Experimental and molecular pathology, 115, 104451. doi:10.1016/j.yexmp.2020.104451. https://pubmed.ncbi.nlm.nih.gov/32417392/